🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. HIPEC with neoadjuvant chemotherapy

    China SXT Pharmaceuticals

    Gastric Cancer

    phase 3 other active

    1 trial

  2. Houyanqing Oral Liquid

    China SXT Pharmaceuticals

    Nasopharyngeal Cancinoma (NPC)

    phase 3 small molecule active

    1 trial

  3. Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)

    China SXT Pharmaceuticals

    Norovirus Infections

    phase 3 mab completed

    1 trial

  4. IAE0972+ Methotrexate

    China SXT Pharmaceuticals

    NPC

    phase 3 mab active

    1 trial

  5. Iloprost

    China SXT Pharmaceuticals

    Pulmonary Arterial Hypertension

    phase 3 small molecule active

    1 trial

  6. Immunonutrition （Su yusu)

    China SXT Pharmaceuticals

    Gastrointestinal Tumors

    phase 3 small molecule active

    1 trial

  7. Inactivated Poliomyelitis Vaccine (Sabin strains)

    China SXT Pharmaceuticals

    Poliomyelitis

    phase 3 mab completed

    2 trials

  8. Individualized Elective Neck Irradiation

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 other active

    1 trial

  9. Intervention

    China SXT Pharmaceuticals

    HIV

    phase 3 other active

    1 trial

  10. Intra-arterial thrombolysis

    China SXT Pharmaceuticals

    Acute Ischemic Stroke

    phase 3 other active

    1 trial

  11. Intravenous nicardipine hydrochloride

    China SXT Pharmaceuticals

    Intracerebral Hemorrhage

    phase 3 small molecule terminated

    1 trial

  12. Intravenous rhTNK-tPA

    China SXT Pharmaceuticals

    Stroke, Acute Ischemic

    phase 3 small molecule active

    1 trial

  13. Intravenous thrombolysis plus tirofiban

    China SXT Pharmaceuticals

    Acute Ischemic Stroke

    phase 3 small molecule completed

    1 trial

  14. KHK7580

    China SXT Pharmaceuticals

    Secondary Hyperparathyroidism

    phase 3 small molecule completed

    1 trial

  15. L-ornithine-L-aspartate

    China SXT Pharmaceuticals

    Decompensated Cirrhosis

    phase 3 small molecule completed

    1 trial

  16. Levamlodipine

    China SXT Pharmaceuticals

    Hypertension

    phase 3 small molecule completed

    1 trial

  17. Levonorgestrel 100 mcg and Ethinyl Estradiol 20 mcg

    China SXT Pharmaceuticals

    Oral Contraceptive

    phase 3 small molecule active

    1 trial

  18. Lipid-lowing Tea

    China SXT Pharmaceuticals

    Hyperlipidemia

    phase 3 small molecule active

    1 trial

  19. Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab

    China SXT Pharmaceuticals

    Immunoglobulin Light-chain Amyloidosis

    phase 3 small molecule active

    1 trial

  20. Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules

    China SXT Pharmaceuticals

    Radiation Proctitis

    phase 3 small molecule active

    1 trial

  21. Loperamide

    China SXT Pharmaceuticals

    Diarrhea-predominant Irritable Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  22. Low-dose complex B-vitamins

    China SXT Pharmaceuticals

    Hyperhomocysteinemia

    phase 3 other completed

    1 trial

  23. MEP

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule terminated

    1 trial

  24. MIE

    China SXT Pharmaceuticals

    Esophageal Carcinoma

    phase 3 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources